Effects of vildagliptin versus sitagliptin, on cardiac function, heart rate variability and mitochondrial function in obese insulin-resistant rats.
about
An Overview of Murine High Fat Diet as a Model for Type 2 Diabetes MellitusGlucagon-like peptide-1 receptor signalling reduces microvascular thrombosis, nitro-oxidative stress and platelet activation in endotoxaemic mice.Combined vildagliptin and metformin exert better cardioprotection than monotherapy against ischemia-reperfusion injury in obese-insulin resistant ratsInvolvement of peroxisome proliferator-activated receptors in cardiac and vascular remodeling in a novel minipig model of insulin resistance and atherosclerosis induced by consumption of a high-fat/cholesterol diet.Obese-insulin resistance accelerates and aggravates cardiometabolic disorders and cardiac mitochondrial dysfunction in estrogen-deprived female rats.Heart Rate Variability as an Alternative Indicator for Identifying Cardiac Iron Status in Non-Transfusion Dependent Thalassemia PatientsA 16-week study to compare the effect of vildagliptin versus gliclazide on postprandial lipoprotein concentrations and oxidative stress in patients with type 2 diabetes inadequately controlled with metformin monotherapy.Inhibition of DPP-4 reduces acute mortality after myocardial infarction with restoration of autophagic response in type 2 diabetic rats.Reduction of serum FABP4 level by sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes mellitus.Vagus Nerve Stimulation Improves Cardiac Function by Preventing Mitochondrial Dysfunction in Obese-Insulin Resistant Rats.DPP-4 Inhibitor and Estrogen Share Similar Efficacy Against Cardiac Ischemic-Reperfusion Injury in Obese-Insulin Resistant and Estrogen-Deprived Female Rats.Sitagliptin prevents inflammation and apoptotic cell death in the kidney of type 2 diabetic animalsThe SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats.Vasonatrin peptide attenuates myocardial ischemia-reperfusion injury in diabetic rats and underlying mechanisms.Biomarkers of oxidative and nitro-oxidative stress: conventional and novel approaches.Cardiac autonomic modulation induced by doxorubicin in a rodent model of colorectal cancer and the influence of fullerenol pretreatment.Alogliptin, a Dipeptidyl Peptidase-4 Inhibitor, Alleviates Atrial Remodeling and Improves Mitochondrial Function and Biogenesis in Diabetic Rabbits.Renoprotective Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin: A Review in Type 2 Diabetes.Protective effects of garlic extract on cardiac function, heart rate variability, and cardiac mitochondria in obese insulin-resistant rats.Impaired mitochondria and intracellular calcium transients in the salivary glands of obese rats.New Antihyperglycemic Drugs and Heart Failure: Synopsis of Basic and Clinical Data.Effect of Ischemic Postconditioning on Myocardial Function and Infarct Size Following Reperfusion Injury in Diabetic Rats Pretreated With Vildagliptin.Trigonelline and vildagliptin antidiabetic effect: improvement of insulin signalling pathway.Comparisons of cardioprotective efficacy between fibroblast growth factor 21 and dipeptidyl peptidase-4 inhibitor in prediabetic rats.Increased sympathovagal imbalance evaluated by heart rate variability is associated with decreased T2* MRI and left ventricular function in transfusion-dependent thalassemia patients.Chronic treatment with prebiotics, probiotics and synbiotics attenuated cardiac dysfunction by improving cardiac mitochondrial dysfunction in male obese insulin-resistant rats.Alleviation of renal mitochondrial dysfunction and apoptosis underlies the protective effect of sitagliptin in gentamicin-induced nephrotoxicity.A Possible Mechanism: Vildagliptin Prevents Aortic Dysfunction through Paraoxonase and Angiopoietin-Like 3.Combination of Vildagliptin and Ischemic Postconditioning in Diabetic Hearts as a Working Strategy to Reduce Myocardial Reperfusion Injury by Restoring Mitochondrial Function and Autophagic Activity.
P2860
Q26740006-550343EC-A339-4969-8436-281B96872C6DQ33434017-0BDFF1F2-D18A-4995-BDBC-2125BDF3137DQ33921334-35CDFE24-1BA9-464F-AF34-9DB59D743A52Q34988827-7A1D36C5-8E2B-4E66-90F0-F98EC46B0B99Q35196735-849A6F1E-C2FC-4D56-B7CF-A3D2E44BEDE5Q35665822-C3F24738-C301-4558-9715-BE4CF01292D0Q35844788-3B3D326F-3327-4CD5-B8F9-04715764E2DCQ35936441-C113A3BD-20D1-4A2F-982E-DF3C24DBEF3CQ36307279-7268DC07-EDBF-430F-926D-9F2E184A838AQ36527088-D94DAF25-F44F-424D-8ED9-6AD8D613F701Q37692285-F01D36EF-C934-449E-B8F1-995DCAB5EBB4Q37725539-843DC949-677C-46F0-831E-0419913C6243Q38698841-4A37B895-A612-4DEE-B11B-84164928D950Q38931035-989F3F39-7CC8-4F77-960C-4D800830964DQ39013839-07BCF670-B449-4E65-B490-ABD08BB7F206Q41072198-27CDA398-AA2D-4C0F-91F5-3E77FFBBBC25Q41104564-2C857ACE-B7EE-49B2-A9D8-1FB3D7BA1513Q42876331-2F4AD911-1E69-4E15-9C3E-A19C52CC598AQ45895086-EA73CF27-C00C-413C-BD72-C4EC00E196D1Q46421196-8F4A4F6F-4BC2-4D22-ADA3-36CCC47B83D1Q47113843-F8D4F7DC-4B44-46C1-B734-F446BCBFD5F4Q47188296-3918972D-D86A-47BA-BF77-9211FC442A87Q48151784-A2245B55-60C9-43E0-ACE3-9AFE11B5E1C4Q48300132-BD88B7F3-559B-4771-9E99-6C583B27C99CQ48539558-2587C387-91AC-4DE6-91D4-048B597539FAQ52682135-3A741946-0622-4452-BB4A-F046B5FD4C1AQ53622968-EB130053-7C62-4A2A-8EF5-FAB3747A67D1Q55382850-F33D2421-32C2-4983-A620-5D67DF4AE7F9Q55724095-A1F96454-7CB3-4AFF-9820-F18015AEC3EC
P2860
Effects of vildagliptin versus sitagliptin, on cardiac function, heart rate variability and mitochondrial function in obese insulin-resistant rats.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Effects of vildagliptin versus ...... obese insulin-resistant rats.
@en
type
label
Effects of vildagliptin versus ...... obese insulin-resistant rats.
@en
prefLabel
Effects of vildagliptin versus ...... obese insulin-resistant rats.
@en
P2093
P2860
P356
P1476
Effects of vildagliptin versus ...... obese insulin-resistant rats.
@en
P2093
Hiranya Pintana
Nattayaporn Apaijai
Siriporn C Chattipakorn
P2860
P304
P356
10.1111/BPH.12176
P407
P577
2013-07-01T00:00:00Z